Showing results (171-180 of 204) with videos related to
Sort By:
Pageof 21
Annals of Internal Medicine|November 1, 1980
Digitoxin-quinidine interaction: pharmacokinetic evaluationP E Fenster, J R Powell, P E Graves, et al.The Journal of Heredity|July 1, 1975
Population genetics of Mexican Drosophila. I. Chromosomal variation in natural populations of Drosophila pseudoobscura from Central MexicoT Dobzhansky, R Felix, J Guzmán, et al.Lipids|January 25, 2002
Influence of dietary supplementation with long-chain n-3 or n-6 polyunsaturated fatty acids on blood inflammatory cell populations and functions and on plasma soluble adhesion molecules in healthy adultsF Thies, E A Miles, G Nebe-von-Caron, et al.Journal of Cardiovascular Pharmacology|June 1, 1989
Preclinical pharmacology of zofenopril, an inhibitor of angiotensin I converting enzymeJ M DeForrest, T L Waldron, J Krapcho, et al.Rejuvenation Research|November 8, 2007
Differential effects of in vitro zinc treatment on gene expression in peripheral blood mononuclear cells derived from young and elderly individualsD J Mazzatti, M Malavolta, A J White, et al.Experimental Gerontology|March 31, 2004
Validation of a new highly standardised, lab-independent whole-blood leukocyte function assay for clinical trials (ILCS)M Schmolz, T L Hurst, D M Bailey, et al.Experimental Gerontology|March 5, 2008
Effects of interleukin-6 -174C/G and metallothionein 1A +647A/C single-nucleotide polymorphisms on zinc-regulated gene expression in ageingD J Mazzatti, M Malavolta, A J White, et al.Pharmaceutical Research|July 1, 1993
Effect of sodium acid pyrophosphate on ranitidine bioavailability and gastrointestinal transit timeK M Koch, A F Parr, J J Tomlinson, et al.Antimicrobial Agents and Chemotherapy|September 1, 1991
Pharmacokinetics of cefuroxime axetil and cefaclor: relationship of concentrations in serum to MICs for common respiratory pathogensN C James, K H Donn, J J Collins, et al.Journal of Cardiovascular Pharmacology|November 1, 1989
Fosinopril, a phosphinic acid inhibitor of angiotensin I converting enzyme: in vitro and preclinical in vivo pharmacologyJ M DeForrest, T L Waldron, C Harvey, et al.Pageof 21